Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma (PRORADGLIO Study)

NCT04747145 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT04747145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04747145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma (PRORADGLIO Study)
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 3, 2021
Completion date
September 30, 2027
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma